<SEC-DOCUMENT>0001628280-23-011502-index.html : 20230413
<SEC-HEADER>0001628280-23-011502.hdr.sgml : 20230413
<ACCEPTANCE-DATETIME>20230413160812
ACCESSION NUMBER:		0001628280-23-011502
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230413
DATE AS OF CHANGE:		20230413
EFFECTIVENESS DATE:		20230413

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Esperion Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001434868
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35986
		FILM NUMBER:		23818454

	BUSINESS ADDRESS:	
		STREET 1:		3891 RANCHERO DRIVE, SUITE 150
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48108
		BUSINESS PHONE:		734-887-3903

	MAIL ADDRESS:	
		STREET 1:		3891 RANCHERO DRIVE, SUITE 150
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HDL THERAPEUTICS INC
		DATE OF NAME CHANGE:	20080513
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>esperion2022annualreportdi.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: esperion2022annualreportdi.pdf

</DOCUMENT>
</SEC-DOCUMENT>